|Turner Overton, MD
Undergraduate: University of Tennessee, Knoxville - English
Post-Baccalaureate: Middle Tennessee State University, Murfeesboro
Medical School: University of Tennessee, Memphis
Rescidency: UAB - Internal Medicine
Fellowship: Barnes-Jewish Hospital and Washington University School of Medicine University - Infectious Diseases
About Dr. Overton
Dr. Overton joined the UAB faculty in 2011 and is currently an Associate Professor in the Division of Infectious Diseases. He serves as the medical director of the UAB 1917 HIV Clinic and Co-Director of the UAB CFAR Clinical Core. His clinical focus involves the improvement of health care delivery to the patients living with HIV and HCV. He oversee all education programs related to HIV for medical and lay persons to fulfill the division mission to train HIV and HCV providers for the future and to raise awareness about these chronic viral infections in the community at large. In his leadership position, he also works closely with clinical and translational researchers who perform their research within the 1917 Clinic or with specimen collected as part of our ongoing 1917 Clinic Cohort. He serves as the Co-Director of the Alabama Vaccine Research Clinic and works closely with Drs. Paul Goepfert and Sonya Heath on a number of projects aimed at developing novel vaccines for HIV and other pathogens. He serves as the HIV Clinical Trials Unit Clinical Site Leader and is a member of the HIV Vaccine Trials Network Protocol Committee and a member of the End Organ Disease/Inflammation Transformative Science Group for the AIDS Clinical Trials Group. He is involved in both of these networks and the development of new studies for HIV prevention and treatment. His research interests focus on the long-term complications of HIV, particularly the interface between persistent inflammation and immune activation as they relate to the increasing prevalence of comorbidities seen among HIV-infected persons and on improving vaccine responses in both healthy and immunocompromised populations. In his spare time, he enjoys reading and time spent in the great outdoors with his family.
- Turner Overton, MD (Infectious Diseases) and colleagues completed an NIH-funded AIDS Clinical Trial Group Study that demonstrated Vitamin D3 plus calcium supplementation mitigates the BMD loss seen with initiation of antiretroviral therapy. Their findings have been published in the Annals of Internal Medicine.